1-3 of 3
David C. Briggs
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Donor KIR Genotype Does Not Affect VZV Reactivation after Allogeneic Haematopoietic Stem Cell Transplantation.

Sujaatha Narayanan, MBBS, Sandeep Nagra, MBChB, Premini Mahendra, MD, FRCPath, Fiona J. Clark, MRCPath, Charles F. Craddock, PhD, FRCPath, Husam Osman, PhD, MRCPath, David C. Briggs, PhD, Paul A. Moss, PhD, FRCPath, Mark A. Cook, MRCPath
Journal: Blood
Blood (2005) 106 (11): 3236.
https://doi.org/10.1182/blood.V106.11.3236.3236
Published: 2005
Journal Articles

Transplant Donor KIR Genotype Influences the Rate of CMV Reactivation Following T-Replete Stem Cell Transplantation.

Mark Cook, David C. Briggs, Charles F. Craddock, Premini Mahendra, Donald Milligan, Christopher Fegan, Philip Darbyshire, Sarah Lawson, Elizabeth Boxall, Paul Moss
Journal: Blood
Blood (2004) 104 (11): 188.
https://doi.org/10.1182/blood.V104.11.188.188
Published: 2004
Journal Articles

The impact of donor KIR and patient HLA-C genotypes on outcome following HLA-identical sibling hematopoietic stem cell transplantation for myeloid leukemia

Mark A. Cook, Donald W. Milligan, Christopher D. Fegan, Philip J. Darbyshire, Premini Mahendra, Charles F. Craddock, Paul A. H. Moss, David C. Briggs
Journal: Blood
Blood (2004) 103 (4): 1521–1526.
https://doi.org/10.1182/blood-2003-02-0438
Published: 2004